What is AarogyaAI?
Founded in 2019 and based in Bengaluru, India, AarogyaAI is dedicated to revolutionizing the diagnosis of drug-resistant TB. Leveraging advanced artificial intelligence, the company aims to provide rapid and accurate diagnostic results within hours, enabling timely and effective prescription of drug combinations for patient treatment. The co-founders, driven by personal experiences with the disease, are committed to addressing the escalating global challenge of DR-TB. AarogyaAI's innovative approach targets a critical bottleneck in TB treatment, promising to improve patient outcomes and contribute to disease elimination efforts.
How much funding has AarogyaAI raised?
AarogyaAI has raised a total of $700K across 1 funding round:
Angel/Seed
$700K
Angel/Seed (2022): $700K with participation from Avaana Capita, Redstart Labs, First In Ventures, Info Edge (India), and Entrepreneur First
Key Investors in AarogyaAI
Info Edge (India)
Info Edge (India) Limited is a leading online classifieds company in India, specializing in recruitment, matrimony, real estate, education, and related services. As one of the few profitable pure play internet companies in the country, it caters to a diverse clientele seeking various online services.
Entrepreneur First
Entrepreneur First is an international Talent Investor, which supports individuals to build technology companies. The company was established in 2011 and is headquartered out of London, UK.
Avaana Capita
Undisclosed investor participating in the funding round.
What's next for AarogyaAI?
The substantial enterprise-level funding and recent strategic investment position AarogyaAI for significant scaling and further technological development. This capital infusion is expected to accelerate the company's go-to-market strategy, enhance its AI diagnostic platform, and expand its reach within India and potentially globally. The focus on DR-TB diagnosis highlights a strategic move into a high-impact area of healthcare, suggesting future growth opportunities in related diagnostic and therapeutic AI applications. AarogyaAI is poised to become a key player in the fight against infectious diseases through technological innovation.
See full AarogyaAI company page
